aTyr Pharma, Inc.

aTyr Pharma, Inc.verified

LIFE

Price:

$1.9

Market Cap:

$131.12M

aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for treatment of other interstitial lung diseases (ILDs), such as chronic hypersensitivity pneumonitis and connective tissue disease related ILD. It is also developing ATYR2810, a fully humanized monoclonal antibody that is in preclinical development for the treatment of solid tumors. It has collaboration and license agreement with Kyorin Pharmaceutical C...[Read more]

Industry

Biotechnology

IPO Date

2015-05-07

Stock Exchange

NASDAQ

Ticker

LIFE

The Enterprise Value as of December 2024 (TTM) for aTyr Pharma, Inc. (LIFE) is 138.44M

According to aTyr Pharma, Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 138.44M. This represents a change of 29.16% compared to the average of 107.18M of the last 4 quarters.

aTyr Pharma, Inc. (LIFE) Historical Enterprise Value (quarterly & annually)

How has LIFE Enterprise Value performed in the past?

The mean historical Enterprise Value of aTyr Pharma, Inc. over the last ten years is 67.58M. The current 138.44M Enterprise Value has changed 20.38% with respect to the historical average. Over the past ten years (40 quarters), LIFE's Enterprise Value was at its highest in in the March 2015 quarter at 292.12M. The Enterprise Value was at its lowest in in the March 2020 quarter at -10502985.20.

Quarterly (TTM)
Annual

Average

67.58M

Median

65.96M

Minimum

7.78M

Maximum

146.97M

aTyr Pharma, Inc. (LIFE) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of aTyr Pharma, Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 579.71%

Maximum Annual Enterprise Value = 146.97M

Minimum Annual Increase = -91.10%

Minimum Annual Enterprise Value = 7.78M

Quarterly (TTM)
Annual
YearEnterprise ValueChange
202368.14M6.81%
202263.79M-54.94%
2021141.58M579.71%
202020.83M167.83%
20197.78M-1.78%
20187.92M-91.10%
201788.94M303.11%
201622.06M-79.53%
2015107.81M-26.65%
2014146.97M21.44%

aTyr Pharma, Inc. (LIFE) Average Enterprise Value

How has LIFE Enterprise Value performed in the past?

The current Enterprise Value of aTyr Pharma, Inc. (LIFE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

3-year avg

91.17M

5-year avg

60.42M

10-year avg

67.58M

aTyr Pharma, Inc. (LIFE) Enterprise Value vs. Peers

How is LIFE’s Enterprise Value compared to its peers?

aTyr Pharma, Inc.’s Enterprise Value is less than Mereo BioPharma Group plc (445.16M), less than Terns Pharmaceuticals, Inc. (234.86M), greater than PDS Biotechnology Corporation (37.39M), less than Inozyme Pharma, Inc. (215.58M), greater than HOOKIPA Pharma Inc. (-37325309.00), greater than X4 Pharmaceuticals, Inc. (79.21M), less than Day One Biopharmaceuticals, Inc. (859.59M), greater than Acumen Pharmaceuticals, Inc. (103.15M), less than Amylyx Pharmaceuticals, Inc. (209.72M),

Build a custom stock screener for aTyr Pharma, Inc. (LIFE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like aTyr Pharma, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

aTyr Pharma, Inc. (LIFE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like aTyr Pharma, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is aTyr Pharma, Inc.'s Enterprise Value?

What is the highest Enterprise Value for aTyr Pharma, Inc. (LIFE)?

What is the 3-year average Enterprise Value for aTyr Pharma, Inc. (LIFE)?

What is the 5-year average Enterprise Value for aTyr Pharma, Inc. (LIFE)?

How does the current Enterprise Value for aTyr Pharma, Inc. (LIFE) compare to its historical average?